Boehringer Ingelheim and CDR-Life Expand Collaboration Efforts with Global Licensing Agreement for CDR111, an Antibody-Based Trispecific M-gager® for Autoimmune Diseases
Notified -
Globe Newswire4-11-2025, 20:00
Solvay highlights innovation and growth opportunities in 1-03-2023, 14:52